Tecan Group is a Switzerland-based provider of laboratory instruments and life science solutions, specializing in automated workflow platforms for research, diagnostics and pharmaceutical applications. The company’s technologies enable precise liquid handling, sample preparation, detection and data management, helping to streamline complex laboratory processes and increase throughput in areas such as genomics, proteomics and drug discovery.
Key products include automated liquid handling workstations, microplate readers and dispensers, robotic solutions for sample management, as well as consumables and software for system control and data analysis. These integrated systems support a wide range of applications—ranging from assay development and high-throughput screening to clinical diagnostics and biobanking—by offering modularity and scalability to meet diverse laboratory requirements.
Founded in 1980 and headquartered in Männedorf, Switzerland, Tecan Group serves customers in more than 80 countries through its global network of subsidiaries, manufacturing sites and distribution partners. The company maintains production facilities in Switzerland, Germany, the United States and China, and provides application support and service offerings to academic institutions, pharmaceutical companies, biotechnology firms and clinical laboratories worldwide.
Under the leadership of Chief Executive Officer Dr. Achim von Leoprechting, Tecan Group continues to invest in research and development, focusing on advances in automation and digital connectivity to address evolving needs in life sciences and diagnostics. The company’s commitment to innovation and quality has established it as a trusted partner for laboratories seeking to improve efficiency and reproducibility in critical workflows.
AI Generated. May Contain Errors.
Free TCHBF Stock Alerts